$26.49
0.281.07%
At close: -
$26.49
0.000500.00%
After Hours: Dec 20, 4:01 PM EDT
Comments
Loading...
BridgeBio Pharma (NASDAQ:BBIO) Stock, Earnings Estimates, EPS, And Revenue
BridgeBio Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 20
EPS Estimate
$-1.090
Quarterly Revenue Estimate
$39.3M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$217.8M
Analyze the earnings history of BridgeBio Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
BridgeBio Pharma (BBIO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-12 | $-0.86 | $-0.98 | 12.2 % |
| Jun 2024 | 2024-08-01 | $-1.06 | $-1.04 | -1.92 % |
| Mar 2024 | 2024-05-02 | $-0.20 | $-0.89 | 77.5 % |
| Dec 2023 | 2024-02-22 | $-0.96 | $-0.91 | -5.49 % |
BridgeBio Pharma (BBIO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-12 | $2.73M | $3.76M | -27.3 % |
| Jun 2024 | 2024-08-01 | $2.17M | $3.57M | -39.3 % |
| Mar 2024 | 2024-05-02 | $211.12M | $14.03M | 1404.8 % |
| Dec 2023 | 2024-02-22 | $1.75M | $6.23M | -72.0 % |
FAQ
When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?
BridgeBio Pharma (BBIO) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for BridgeBio Pharma (NASDAQ:BBIO)?
The Actual EPS was $-0.86, which beat the estimate of $-0.98.
What were BridgeBio Pharma’s (NASDAQ:BBIO) revenues?
The Actual Revenue was $2.7M, which missed the estimate of $3.8M.
Browse earnings estimates, EPS, and revenue on all stocks.